| |MARCH 20264The Indian injectable manufacturing market is showcasing robust demand for biologics, and increased capacity in generic injectables Today, the key trends include AI-driven production, CDMO growth, and prefilled syringes. However, the industry comes with its own set of dire challenges that revolve around stringent USFDA compliance, high capital investment, and complex sterility validations. Hence, all the stakeholders must bring in their involvement to drive this sector further. One trend that has been showcasing quite the traction has to be the third-party manufacturing with contract manufacturers seeing >7 percent CAGR, driven by demand for biologics and specialized sterile products in India. Furthermore, the integration of automation, Industry 4.0, and AI has significantly improved the production speed, accuracy, and quality compliance. There is also a high demand for complex generic formulations, biosimilars, and ready-to-use prefilled syringes while industry shifts slowly toward green chemistry and reduced carbon footprints in manufacturing processes. Today, ICRA projects total capital expenditure for Indian pharma at INR 42,00045,000 crore in FY2026, with substantial inorganic investments in sterile capabilities. This is further coupled with the strategic partnerships between Indian manufacturers and foreign companies facilitating technology transfer and market access. As pharma is a highly regulated sector, the country is staying at par with the international standards with high emphasis on compliance with international standards such as USFDA, WHO-GMP, and ISO to support export growth, with over 50% of exports targeting regulated markets.Recognizing the importance of injectable manufacturers in the realm of pharmaceuticals, India Pharma Outlook presents - `Top 10 Injectable Manufacturers - 2026.' This highly scrutinized edition has been crafted to showcase some of the most promising manufacturers of injectables in India. These nominated players have been shortlisted due to their prowess in offering best-in-class product solutions that are benchmarked as per the industry standards.Shiwani Pradhan Assistant Editoreditor@indiapharmaoutlook.comSetting Benchmarks in Injectable ManufacturingVol 5 · Issue 05 - 03 · MARCH , 2026Publisher Alok ChaturvediManaging EditorSamrat Pradhan Assistant EditorShiwani Pradhan Editorial TeamViswanathan AThiruamuthan T K Lakshmi Prabha GM - Media & Graphic Designing VisualizerPrabhu DuttaDesignerRutika MohantyMonalisha Malik Advertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2026 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
<
Page 3 |
Page 5 >